share_log

Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Healthcare Triangle, Inc. 公佈2023年第四季度和全年財務業績
GlobeNewswire ·  03/15 09:28

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("Healthcare Triangle," "HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics and AI data processing for the healthcare and life sciences industries, today announced financial results for its fourth quarter and full year ended December 31, 2023.

加利福尼亞州普萊森頓,2024年3月15日(GLOBE NEWSWIRE)——醫療保健和生命科學行業數字化轉型解決方案的領導者,包括醫療保健和生命科學行業的託管服務、雲支持、網絡安全、數據分析和人工智能數據處理,三角醫療保健公司(納斯達克股票代碼:HCTI)(“醫療三角” 或 “公司”)今天公佈了截至2023年12月31日的第四季度和全年財務業績。

Fourth Quarter 2023 Financial Results

2023 年第四季度財務業績

  • Revenue: Total revenue was $7.1 million, representing a decrease of 37% compared to the fourth quarter of 2022. Revenue from the Software Services and Managed Services segments decreased by 40% and 37%, respectively, partially offset by a 22% increase in Platform Services.
  • GAAP loss from operations: GAAP loss from operations was $5.3 million, compared to $4.9 million in the fourth quarter of 2022. The increased loss was primarily due to impairment of intangibles and goodwill. The one-time impact of the impairment was $4.2 million. The normalized GAAP loss from operations was $0.7 million.
  • GAAP net loss per share: GAAP basic and diluted net loss per share was $1.26 based on 4.2 million weighted-average shares outstanding, compared to $1.33 based on 3.6 million weighted-average shares outstanding in the year-ago quarter.
  • 收入:總收入爲710萬美元,與2022年第四季度相比下降了37%。軟件服務和託管服務板塊的收入分別下降了40%和37%,部分被平台服務22%的增長所抵消。
  • GAAP運營虧損:GAAP運營虧損爲530萬美元,而2022年第四季度爲490萬美元。虧損增加的主要原因是無形資產和商譽減值。減值的一次性影響爲420萬美元。正常的GAAP運營虧損爲70萬美元。
  • GAAP每股淨虧損:根據420萬股已發行加權平均股票,GAAP基本淨虧損和攤薄後每股淨虧損爲1.26美元,而去年同期已發行的360萬股加權平均股爲1.33美元。

Full Year 2023 Financial Results

2023 年全年財務業績

  • Revenue: Total revenue was $33.2 million, representing a decrease of 28% compared to 2022. Revenue from Software Services, Managed Services and Support and Platform Services revenue has decreased in the current year.
  • GAAP loss from operations: GAAP loss from operations was $12.3 million, compared to $9.6 million in 2022. The increased loss was primarily due to impairment of intangibles and goodwill. The onetime impact of the impairment was $4.2 million. The normalized GAAP loss from operations was $8.1 million.
  • GAAP net loss per share: GAAP basic and diluted net loss per share was $2.92 based on 4.2 million weighted-average shares outstanding, compared to $2.63 based on 3.6 million weighted-average shares outstanding in 2022.
  • Cash and cash equivalents totaled $1.2 million as of December 31, 2023.
  • 收入:總收入爲3,320萬美元,與2022年相比下降了28%。本年度,軟件服務、託管服務和支持以及平台服務收入的收入有所下降。
  • GAAP運營虧損:GAAP運營虧損爲1,230萬美元,而2022年爲960萬美元。虧損增加的主要原因是無形資產和商譽減值。減值造成的一次性影響爲420萬美元。正常的GAAP運營虧損爲810萬美元。
  • GAAP每股淨虧損:根據420萬股加權平均已發行股票,GAAP基本淨虧損和攤薄後每股淨虧損爲292美元,而根據2022年已發行的360萬股加權平均股票,GAAP基本淨虧損和攤薄後的每股淨虧損爲2.63美元。
  • 截至2023年12月31日,現金及現金等價物總額爲120萬美元。

Business Highlights:

業務亮點:

  • Secured a new $3 million contract to provide HITRUST-certified Cloud DevOps Managed Services for a leading life sciences customer, reinforcing the Company's position as a top player in the Cloud DevOps Managed Services business.
  • Secured a multi-year program expansion contract with a Fortune 500 biopharmaceutical company, securing our position as one of the providers for Cloud DevOps, data engineering and data platform management solutions.
  • Announced a multi-year subscription agreement with a long-standing customer for readabl.ai, a medical document automation solution aimed at streamlining patient care and reducing operating costs.
  • Launched a new ransomware protection and prevention initiative drawing initial interest and support from numerous health system clients. The Company is servicing multiple contract agreements for cloud backup and disaster recovery, allowing hospitals and health systems to move disaster recovery to the Amazon Web Services (AWS) cloud to secure resources and scale on demand.
  • Hosted sessions on digital transformation and ransomware preparedness for healthcare systems at CHIME23 fall forum.
  • Hosted roundtable discussion on generative AI and data modernization strategies for healthcare and hosted webinar addressing ransomware preparedness for healthcare.
  • Participated in 2023 MUSE Inspire conference as exhibitor and host of best practice sessions and at HIMSS23 conference as a guest speaker for Amazon Web Services.
  • 獲得了一份價值300萬美元的新合同,爲一家領先的生命科學客戶提供經Hitrust認證的雲開發運營管理服務,鞏固了公司作爲雲開發運營託管服務業務領先者的地位。
  • 與一家財富500強生物製藥公司簽訂了爲期多年的項目擴展合同,確保了我們作爲雲開發運營、數據工程和數據平台管理解決方案提供商之一的地位。
  • 宣佈與一位長期客戶 readabl.ai 簽訂多年期訂閱協議,這是一種醫療文檔自動化解決方案,旨在簡化患者護理和降低運營成本。
  • 啓動了一項新的勒索軟件保護和預防計劃,獲得了衆多衛生系統客戶的初步興趣和支持。該公司正在爲多份雲備份和災難恢復合同協議提供服務,允許醫院和醫療系統將災難恢復轉移到亞馬遜網絡服務 (AWS) 雲,以保護資源並按需擴展。
  • 在 CHIME23 秋季論壇上主持了關於醫療保健系統的數字化轉型和勒索軟件防範的會議。
  • 主持了關於醫療保健行業生成式人工智能和數據現代化策略的圓桌討論,並主持了有關醫療保健領域勒索軟件防範工作的網絡研討會。
  • 作爲參展商和最佳實踐會議主持人蔘加了 2023 年 MUSE Inspire 會議,並作爲亞馬遜網絡服務的演講嘉賓參加了 HIMSS23 會議。

Thyagarajan Ramachandran, Chief Financial Officer of Healthcare Triangle, stated, "Despite experiencing a decline in revenue throughout the year, we achieved significant milestones by launching some key initiatives in ransomware protection and preparedness for our clients. During the year we secured notable multi-year contracts. We believe the steps we have taken will make us a top provider of cybersecurity solutions as well as a leading provider in AI-driven healthcare process and workflow in the future. Because of the work we completed during full year 2023, we have already seen the fruits of our labor lead to many new initiatives in 2024. The Company is in multiple discussions with healthcare companies looking at our AI solutions to bring their existing systems up to date and creating new standards while providing potential cost savings and productivity gains. The healthcare landscape is continually evolving, generating a significant amount of data on a daily basis, driven by patient care, payment systems, regulatory compliance and recordkeeping. HCTI continues to be a leader in innovation as we make improvements to our HITRUST-certified Cloud DevOps managed services and AI adoption. AI in the healthcare market is projected to reach $53 billion by 2024, according to Grand View Research, and this presents many opportunities for documentation AI and generative AI for us and our solutions. A key strategy for both customer acquisition as well as marketing and brand visibility has been educating potential customers and the industry at large by hosting webinars and participating in conferences and guest speaking. We believe we are positioned ideally and have made major strides in 2023."

Healthcarajan Ramachandran首席財務官Thyagarajan Ramachandran表示:“儘管全年收入有所下降,但我們在勒索軟件保護和爲客戶做好準備方面啓動了一些關鍵舉措,取得了重要的里程碑。在這一年中,我們獲得了值得注意的多年期合同。我們相信,我們所採取的措施將使我們成爲網絡安全解決方案的頂級提供商,以及未來人工智能驅動的醫療保健流程和工作流程的領先提供商。由於我們在2023年全年完成的工作,我們已經看到我們的勞動成果在2024年帶來了許多新舉措。該公司正在與醫療保健公司進行多次討論,研究我們的人工智能解決方案,以使其現有系統保持最新狀態並創建新標準,同時提供潛在的成本節省和生產率的提高。醫療保健格局在不斷變化,在患者護理、支付系統、監管合規和記錄保存的推動下,每天都會生成大量數據。隨着我們對經Hitrust認證的Cloud DevOps託管服務和人工智能採用進行改進,HCTI仍然是創新領域的領導者。根據Grand View Research的數據,到2024年,醫療保健市場的人工智能預計將達到530億美元,這爲我們和我們的解決方案提供了許多記錄人工智能和生成人工智能的機會。獲取客戶以及營銷和品牌知名度的關鍵策略是通過舉辦網絡研討會、參加會議和嘉賓演講來教育潛在客戶和整個行業。我們相信我們的定位理想,並在2023年取得了長足的進步。”

About Healthcare Triangle:

關於醫療保健三角:

Healthcare Triangle, Inc., headquartered in Pleasanton, California, stands at the forefront of healthcare technology, specializing in AI and digital transformation. With a commitment to innovation, collaboration, and excellence, Healthcare Triangle is dedicated to reshaping healthcare delivery for the better. We collaborate with healthcare entities, including hospitals, health systems, payers, and pharma/life sciences organizations, leveraging breakthrough technology and extensive industry expertise to enhance health outcomes through optimized data utilization and cutting-edge information technologies. Holding HITRUST Certification for Cloud and Data Platform (CaDP) – featuring CloudEz, DataEz, and readabl.ai – our commitment to the highest standards in data protection and information security is unwavering. Healthcare Triangle serves as a beacon for the adoption of new technologies, data enlightenment, business agility, and swift response to evolving business needs and competitive challenges. Thriving in the highly regulated healthcare and life sciences sectors, we excel in digital transformation encompassing the cloud, security and compliance, identity management, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit .

總部位於加利福尼亞州普萊森頓的Healthcare Triangle, Inc. 站在醫療保健技術的最前沿,專門從事人工智能和數字化轉型。Healthcare Triangle 致力於創新、協作和卓越,致力於重塑醫療保健服務,使其變得更好。我們與醫療保健實體合作,包括醫院、衛生系統、支付方和製藥/生命科學組織,利用突破性技術和廣泛的行業專業知識,通過優化數據利用和尖端信息技術來改善健康成果。持有 HITRUST 雲和數據平台 (CadP) 認證 — 以 CloudeZ 爲特色,DataEZ,以及 readabl.ai — 我們對數據保護和信息安全的最高標準的承諾堅定不移。Healthcare Triangle 是採用新技術、數據啓發、業務敏捷性以及快速應對不斷變化的業務需求和競爭挑戰的燈塔。我們在高度監管的醫療保健和生命科學領域蓬勃發展,在數字化轉型方面表現出色,包括雲、安全與合規、身份管理、數據生命週期管理、醫療互操作性以及臨床和業務績效優化。欲了解更多信息,請訪問。

Forward-Looking Statements and Safe Harbor Notice

前瞻性陳述和安全港通知

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on March 28, 2023, subsequent filings and future reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

本新聞稿中除歷史事實陳述以外的所有陳述均爲 “前瞻性陳述”(定義見1995年《私人證券訴訟改革法》)。此類前瞻性陳述包括我們的預期以及那些使用前瞻性詞語的陳述,例如 “預期”、“預期”、“可能性” 和 “預期”。此類前瞻性陳述所涵蓋事項的成就或成功涉及重大風險、不確定性和假設。實際結果可能與當前的預測或隱含的結果存在重大差異。投資者應閱讀公司於2023年3月28日向美國證券交易委員會提交的10-K表年度報告、隨後向美國證券交易委員會提交的文件和未來報告中列出的風險因素。公司的所有前瞻性陳述均受所有此類風險因素和其他警示性陳述的明確限制。

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time the statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

公司警告說,本新聞稿中的陳述和假設構成前瞻性陳述,不能保證未來的表現。前瞻性陳述基於發表聲明時管理層的估計和意見。此處提供的信息僅代表截至本文發佈之日。在本新聞發佈之日之後,公司及其管理層沒有義務修改這些聲明。

Contacts

聯繫人

Investors:
1-800-617-9550
ir@healthcaretriangle.com

投資者:
1-800-617-9550
ir@healthcaretriangle.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論